# Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

> **NCT00053430** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Thalidomide
- **DRUG:** Thalidomide placebo

## Key facts

- **NCT ID:** NCT00053430
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2005-08
- **Final completion:** 2006-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00053430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00053430, "Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00053430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*